U.S. markets closed

Solid Biosciences Inc. (SLDB)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
3.4900-0.9500 (-21.40%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 5/12/2021
Current
12/31/20209/30/20206/30/20203/31/2020
Market Cap (intraday) 5
510.68M643.50M93.74M134.98M110.11M
Enterprise Value 3
361.08M624.35M59.44M88.01M33.65M
Trailing P/E
N/AN/AN/AN/AN/A
Forward P/E 1
N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/A
Price/Sales (ttm)
N/AN/AN/AN/AN/A
Price/Book (mrq)
3.8728.952.302.391.38
Enterprise Value/Revenue 3
N/AN/AN/AN/AN/A
Enterprise Value/EBITDA 7
-4.37-30.38-2.91-4.99-1.41

Trading Information

Stock Price History

Beta (5Y Monthly) 0.99
52-Week Change 319.93%
S&P500 52-Week Change 341.30%
52 Week High 311.5800
52 Week Low 31.9300
50-Day Moving Average 35.0129
200-Day Moving Average 35.8458

Share Statistics

Avg Vol (3 month) 31.73M
Avg Vol (10 day) 31.02M
Shares Outstanding 5110.3M
Implied Shares Outstanding 6N/A
Float 32.92M
% Held by Insiders 117.47%
% Held by Institutions 164.79%
Shares Short (Apr 29, 2021) 45.63M
Short Ratio (Apr 29, 2021) 47.01
Short % of Float (Apr 29, 2021) 49.53%
Short % of Shares Outstanding (Apr 29, 2021) 45.10%
Shares Short (prior month Mar 30, 2021) 45.64M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Dec 30, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-39.35%
Return on Equity (ttm)-83.24%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -82.54M
Net Income Avi to Common (ttm)-88.29M
Diluted EPS (ttm)-1.7000
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)154.74M
Total Cash Per Share (mrq)1.82
Total Debt (mrq)5.15M
Total Debt/Equity (mrq)3.90
Current Ratio (mrq)6.49
Book Value Per Share (mrq)1.56

Cash Flow Statement

Operating Cash Flow (ttm)-56.6M
Levered Free Cash Flow (ttm)-34.85M